Peripheral neuropathy decisions — 2026

The Board has dismissed the Veteran's claims for service connection for peripheral neuropathy of both upper extremities as they have been granted and rendered moot.

The Board has granted service connection for type 2 diabetes mellitus and diabetic peripheral neuropathy of the bilateral upper and lower extremities, finding that these conditions are related to the Veteran's active duty service.

The Board has remanded the claims for Guillain barre syndrome, left lower extremity neuropathy, right lower extremity neuropathy, left upper extremity neuropathy, and right upper extremity neuropathy due to untimely filing of a VA Form 9. The RO is instructed to review all newly received medical and lay evidence and readjudicate the claims.

The Veteran's bilateral eye disability is not service-connected as it was not shown to have begun during his period of active duty or be related to an in-service injury.,The Veteran's right and left knee disabilities are not service-connected as they were not shown to have begun during his period of active duty or be related to an in-service injury.

The Veteran's hypertension is granted on a presumptive basis due to herbicide agent exposure. The claims for right upper and left upper extremity peripheral neuropathy are denied.

The Board has determined that additional development is needed to address the service connection claims for diabetes mellitus, type II and its related peripheral neuropathy of the lower extremities due to duty-to-assist errors.

The Veteran's effective dates for the awards of a 40 percent rating for bilateral lower extremity sciatic peripheral neuropathy and service connection for bilateral lower extremity femoral peripheral neuropathy have been granted as of June 26, 2023.

The Board has remanded the Veteran's claims for service connection for low red blood cell count, obstructive sleep apnea (OSA), chronic kidney disease, diabetes mellitus type II (DMII), hypertension, left lower extremity peripheral neuropathy as secondary to DMII, left upper extremity peripheral neuropathy as secondary to DMII, right lower extremity peripheral neuropathy as secondary to DMII, and right upper extremity peripheral neuropathy as secondary to DMII due to the need for additional National Guard records and a VA examination.

The Veteran withdrew his appeals for the issues of service connection for bilateral upper extremity neuropathy, bilateral lower extremity neuropathy, diabetic retinopathy and erectile dysfunction due to satisfaction with a total disability rating based on individual unemployability.

The Veteran's application for PCAFC enrollment was denied due to a lack of evidence and legal deficiencies in the decision. The Board has ordered remand to obtain additional medical records, correct notification issues, and provide a new medical determination based on all relevant evidence.

The Board has remanded the case due to insufficient medical opinions regarding the Veteran's vertigo claim. The claims for diabetes and diabetic neuropathy of the left lower extremity remain denied.

The Veteran was granted an earlier effective date of August 25, 2014 for his TDIU and DEA eligibility.,An earlier effective date of April 28, 2021 was denied for the award of SMC at the housebound rate.

The Veteran's service-connected disabilities, including diabetic neuropathy and peripheral neuropathy of the upper and lower extremities, tinnitus, and diabetes mellitus type II, have rendered him unable to secure or follow a substantially gainful occupation. The Board has granted his claim for TDIU.

The Board has remanded the claim for SMC based on aid and attendance due to a pre-decisional error in not considering evidence submitted by the Veteran within the applicable evidentiary window. The AOJ is required to obtain an opinion from an appropriate clinician regarding whether the Veteran's service-connected disabilities result in the need for A&A.

The Veteran's claim for increased ratings for diabetic peripheral neuropathy in multiple extremities was denied. The Board found that the evidence did not support a finding of medically necessary regulation of activities due to diabetes, which is required for a higher rating.,The Veteran also had his TDIU granted effective from June 15, 2023 until August 7, 2024 and from October 1, 2025.

The Board denied service connection for peripheral neuropathy of the upper and lower extremities, hypertension, gastrointestinal disability, bilateral eye disability, and psychiatric disorder due to presumed exposure to herbicide agents in Korea. The Veteran's claims were remanded for consideration of obstructive sleep apnea.

Your appeal has been dismissed due to the Veteran's death. The Board cannot issue a decision on your claims as they are no longer pending.

The Board has determined that the March 2025 rating decision did not address all of the Veteran's service connection claims, including those for diabetes mellitus type II, coronary artery disease, hypertension, peripheral neuropathy, and kidney disorder. The AOJ must provide a TERA examination and medical opinion if necessary to establish service connection for these conditions.

The Board has remanded the issues of service connection for diabetes mellitus, type II (DM) and neuropathies of the right lower extremity, left lower extremity, right upper extremity, and left upper extremity due to duty-to-assist errors.

The Board denied the Veteran's claims for service connection for peripheral neuropathy of the bilateral upper and lower extremities, finding no current diagnosis of the claimed disability.